Members of the
cadherin family have been implicated as growth regulators in multiple
tumor types. Based on recent studies from our laboratory implicating
T-cadherin expression in mouse brain
tumorigenesis, we examined the role of
T-cadherin in
astrocytoma growth regulation. In this report, we show that
T-cadherin expression increased during primary astrocyte physiologic growth arrest in response to contact inhibition and serum
starvation in vitro, suggesting a function for
T-cadherin in astrocyte growth regulation. We further demonstrate that transient and stable reexpression of
T-cadherin in deficient C6
glioma cell lines results in growth suppression. In addition,
T-cadherin-expressing C6 cell lines demonstrated increased homophilic cell aggregation, increased cell attachment to
fibronectin, and decreased cell motility. Cell cycle flow cytometry demonstrated that
T-cadherin reexpression resulted in G2 phase arrest, which was confirmed by mitotic index analysis. This growth arrest was p53 independent, as
T-cadherin could still mediate growth suppression in p53(-/-) mouse embryonic fibroblasts.
T-cadherin-expressing C6 cell lines exhibited increased p21(CIP1/WAF1), but not p27(Kip1), expression. Lastly,
T-cadherin-mediated growth arrest was dependent on p21(CIP1/WAF1) expression and was eliminated in p21(CIP1/WAF1)-deficient fibroblasts. Collectively, these observations suggest a novel mechanism of growth regulation for
T-cadherin involving p21(CIP1/WAF1) expression and G2 arrest.